Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Forsgren

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
European Journal of Immunology|May 1, 1988
Role of the 2H4 molecule in the activation of suppressor inducer functionC Morimoto, T Matsuyama, C E Rudd, et al.
Physics in Medicine and Biology|July 18, 2024
Robust optimization strategies for contour uncertainties in online adaptive radiation therapyA Smolders, I Bengtsson, A Forsgren, et al.
Journal of Medical Microbiology|June 1, 1991
Human lactoferrin binding in clinical isolates of Staphylococcus aureusA S Naidu, J Miedzobrodzki, J M Musser, et al.
The Journal of Infectious Diseases|August 7, 1999
Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue culturesH Janson, B Carl n, A Cervin, et al.
Vaccine|February 13, 2001
Developing a nontypeable Haemophilus influenzae (NTHi) vaccineJ T Poolman, L Bakaletz, A Cripps, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1994
European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacinI Phillips, J Acar, F Baquero, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1991
Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infectionsS S Naidu, J Erdei, E Czirók, et al.
Clinical and Experimental Immunology|July 1, 1987
A sulfhydryl-rich IgM protein with multiple serological specificitiesG Merlini, O Zettervall, A Forsgren, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 9, 2010
Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strainsF Resman, M Ristovski, J Ahl, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coliI Gadó, J Erdei, V G Laszlo, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Immunology|May 1, 1988
Role of the 2H4 molecule in the activation of suppressor inducer functionC Morimoto, T Matsuyama, C E Rudd, et al.
Physics in Medicine and Biology|July 18, 2024
Robust optimization strategies for contour uncertainties in online adaptive radiation therapyA Smolders, I Bengtsson, A Forsgren, et al.
Journal of Medical Microbiology|June 1, 1991
Human lactoferrin binding in clinical isolates of Staphylococcus aureusA S Naidu, J Miedzobrodzki, J M Musser, et al.
The Journal of Infectious Diseases|August 7, 1999
Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue culturesH Janson, B Carl n, A Cervin, et al.
Vaccine|February 13, 2001
Developing a nontypeable Haemophilus influenzae (NTHi) vaccineJ T Poolman, L Bakaletz, A Cripps, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1994
European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacinI Phillips, J Acar, F Baquero, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1991
Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infectionsS S Naidu, J Erdei, E Czirók, et al.
Clinical and Experimental Immunology|July 1, 1987
A sulfhydryl-rich IgM protein with multiple serological specificitiesG Merlini, O Zettervall, A Forsgren, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 9, 2010
Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strainsF Resman, M Ristovski, J Ahl, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1991
Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coliI Gadó, J Erdei, V G Laszlo, et al.
Pageof 21